SCHEMBL190281

SCHEMBL190281

O=C1CCS(=O)(=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL561522 0.80
SCHEMBL11532547 0.80 TRIM24 (0.53)
Cyclopentanone SCHEMBL28195072 0.78 TRIM24 (0.59)
SCHEMBL64228 0.71
SCHEMBL119955 0.71
SCHEMBL7981543 0.71
SCHEMBL135681 0.69
SCHEMBL12006494 0.69
SCHEMBL5457895 0.69
SCHEMBL11960019 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119528956-B BODIPY light-cage chemiluminescent molecule, nano microsphere, and synthesis method and application thereof 中南林业科技大学 2025-05-13 CN claimed
CN-119528956-A BODIPY light-cage chemiluminescent molecule, nano microsphere, and synthesis method and application thereof 中南林业科技大学 2025-02-28 CN claimed
CN-111349061-B Synthesis method of tetrahydrothiopyran-4-one 1, 1-dioxide 河北圣泰材料股份有限公司 2022-09-06 CN claimed
CN-111349061-A Synthesis method of tetrahydrothiopyran-4-one 1, 1-dioxide 石家庄圣泰化工有限公司 2020-06-30 CN claimed
US-20260116869-A1 AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS NOVARTIS AG (CH) 2026-04-30 US disclosed
EP-3814356-B1 TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS ZHEJIANG VIMGREEN PHARMACEUTICALS LTD (CN) 2026-03-11 EP disclosed
US-20260066324-A1 REDOX CYCLABLE MOLECULES FOR ENERGY STORAGE MICROSOFT TECHNOLOGY LICENSING LLC (US) 2026-03-05 US disclosed
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2026-02-17 US disclosed
EP-3950682-B1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) 2026-02-11 EP disclosed
EP-4676476-A1 INHIBITORS OF TDP-43 AND TAU AGGREGATION Aquinnah Pharmaceuticals, Inc. (US) 2026-01-14 EP disclosed
EP-4673440-A1 INHIBITORS OF LRRK2 Vanderbilt University (US) 2026-01-07 EP disclosed
US-20250381206-A1 INVARIANT NATURAL KILLER T-CELL ACTIVATORS DECIDUOUS THERAPEUTICS, INC. (US) 2025-12-18 US disclosed
EP-1173472-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-23 EP disclosed
US-6326359-B1 PURINE DERIVATIVES PFIZER INC 2001-12-04 US disclosed
US-6262044-B1 CONTAINING AN AMIDE-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE RING NOVO NORDISK A/S (DK) 2001-07-17 US disclosed
WO-2000064927-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 WO disclosed
US-5352802-A Derivatives of 4H-thiopyran-1,1-dioxide EASTMAN KODAK COMPANY (US) 1994-10-04 US disclosed
US-5300385-A Low voltage, high speed EASTMAN KODAK COMPANY (US) 1994-04-05 US disclosed
US-4370323-A 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes BOEHRINGER MANNHEIM GMBH (DE) 1983-01-25 US disclosed
US-3991076-A Aminoalkylthiopyranopyrroles AMERICAN HOECHST CORPORATION (US) 1976-11-09 US disclosed